Stockreport

Kyowa Kirin Presents Real-World Evidence Demonstrating Clinically Meaningful Impact of Burosumab Treatment in Adults with X-linked Hypophosphatemia

KIRIN HLDGS CO LTD S/ADR  (KNBWY) 
US:NASDAQ Investor Relations: kirinholdings.co.jp/english/ir
PDF Findings from UK burosumab early access program spotlighted in oral presentation at ASBMR annual meetingStatistically significant improvements seen in patient-reported m [Read more]